INS and diabetes mellitus: This association has been observed in rodent models having the proinsulin-misfolding mutants, in humans with Mutant INS-gene-induced Diabetes of Youth (MIDY), and with mutations in the critical ER-resident proteins [10], as well as in patients with type 2 diabetes [9].